Opportunity

Simpler Grants.gov #362272

Translational Research Award for Traumatic Brain Injury and Psychological Health

Buyer

Dept. of the Army -- USAMRAA

Posted

May 06, 2026

Respond By

October 15, 2026

Identifier

362272

NAICS

541715

The Dept. of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is soliciting proposals for the Translational Research Award (TRA) focused on Traumatic Brain Injury and Psychological Health. - Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - OEMs and Vendors: - No specific OEMs or vendors are mentioned in the solicitation - Products/Services Requested: - Translational research services to accelerate scientific findings into clinical applications - Focus on innovative approaches for Traumatic Brain Injury and Psychological Health - Two research levels: - Level 1: Refinement of mature ideas into tangible products - Level 2: Rigorous evaluation for first-in-human studies or clinical trials - Early-Career Investigator Partnering Option available (two Principal Investigators may receive separate awards) - Applications must include preliminary data - Animal research must describe relevance to human clinical conditions - Human subject research must include community-based participatory research - Unique/Notable Requirements: - Basic research and clinical trials are prohibited - Preliminary data required - Community-based participatory research required for human subjects - Estimated funding: $9,000,000 for six awards - Eligibility is unrestricted - Place of Performance: - US Army Medical Research Acquisition Activity (USAMRAA)

Description

The Translational Research Award (TRA) aims to accelerate the conversion of scientific findings into impactful clinical applications, prioritizing innovative approaches over incremental research. Basic research and clinical trials are prohibited, and preliminary data are required. The award supports two research levels: Level 1 for refining mature ideas into tangible products, and Level 2 for rigorous evaluation in preparation for first-in-human studies or clinical trials. An Early-Career Investigator Partnering Option is available, allowing two Principal Investigators to receive separate awards if funded.

View original listing